1. Home
  2. PTCT vs BHF Comparison

PTCT vs BHF Comparison

Compare PTCT & BHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • BHF
  • Stock Information
  • Founded
  • PTCT 1998
  • BHF 2016
  • Country
  • PTCT United States
  • BHF United States
  • Employees
  • PTCT N/A
  • BHF N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • BHF Life Insurance
  • Sector
  • PTCT Health Care
  • BHF Finance
  • Exchange
  • PTCT Nasdaq
  • BHF Nasdaq
  • Market Cap
  • PTCT 3.9B
  • BHF 3.4B
  • IPO Year
  • PTCT 2013
  • BHF N/A
  • Fundamental
  • Price
  • PTCT $48.55
  • BHF $49.65
  • Analyst Decision
  • PTCT Buy
  • BHF Hold
  • Analyst Count
  • PTCT 14
  • BHF 10
  • Target Price
  • PTCT $63.57
  • BHF $57.70
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • BHF 921.5K
  • Earning Date
  • PTCT 08-07-2025
  • BHF 08-07-2025
  • Dividend Yield
  • PTCT N/A
  • BHF N/A
  • EPS Growth
  • PTCT N/A
  • BHF N/A
  • EPS
  • PTCT 7.51
  • BHF 8.45
  • Revenue
  • PTCT $1,772,758,000.00
  • BHF $8,610,000,000.00
  • Revenue This Year
  • PTCT $121.50
  • BHF $41.29
  • Revenue Next Year
  • PTCT N/A
  • BHF $2.39
  • P/E Ratio
  • PTCT $6.45
  • BHF $5.78
  • Revenue Growth
  • PTCT 91.12
  • BHF 165.09
  • 52 Week Low
  • PTCT $29.02
  • BHF $40.00
  • 52 Week High
  • PTCT $58.38
  • BHF $64.12
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 46.94
  • BHF 29.45
  • Support Level
  • PTCT $47.52
  • BHF $50.61
  • Resistance Level
  • PTCT $49.73
  • BHF $54.72
  • Average True Range (ATR)
  • PTCT 1.46
  • BHF 2.35
  • MACD
  • PTCT -0.19
  • BHF -0.45
  • Stochastic Oscillator
  • PTCT 36.28
  • BHF 8.05

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About BHF Brighthouse Financial Inc.

Brighthouse Financial Inc is a United States-based provider of annuity products and life insurance through independent distribution channels and marketing arrangements with distribution partners. Its segments are Annuities, Life, Run-off and Corporate and Other. It derives a majority of the revenue from the Annuities segment which includes variable, fixed, index-linked, and income annuities. The life segment includes variable, term, universal, and whole life policies.

Share on Social Networks: